电话:
+86 (0512) 65829739
传真:
+86 (010) 6788 5057
电子邮件:
orders@antibodies-online.cn

Claudin 7 抗体 (C-Term) (FITC)

This FITC-conjugated 兔 多克隆 anti-Claudin 7 antibody specifically detects Claudin 7 in WB, ELISA, IHC 和 FACS. The antibody is reactive with 人 samples.
产品编号 ABIN2234591
发货至: 中国
Contact our Customer Service for availability and price in your country. Contact Info

Our Local Distributor

中国
北京 101111
No. 88 KeChuang 6th Street
Beijing Economic Technological Development Area
Room 801-803
4A Biotech Co.,Ltd.
Tel +86 (0512) 65829739 传真 +86 (010) 6788 5057

Quick Overview for Claudin 7 抗体 (C-Term) (FITC) (ABIN2234591)

抗原

See all Claudin 7 (CLDN7) 抗体
Claudin 7 (CLDN7)

适用

  • 62
  • 25
  • 24
  • 4
  • 3
  • 2
  • 2
  • 2
  • 2
  • 1

宿主

  • 60
  • 2

克隆类型

  • 60
  • 2
多克隆

标记

  • 33
  • 3
  • 3
  • 2
  • 2
  • 2
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
This Claudin 7 antibody is conjugated to FITC

应用范围

  • 36
  • 30
  • 23
  • 14
  • 14
  • 13
  • 12
  • 7
  • 3
  • 3
  • 3
  • 2
Western Blotting (WB), ELISA, Immunohistochemistry (IHC), Flow Cytometry (FACS)
  • 抗原表位

    • 15
    • 11
    • 11
    • 7
    • 4
    • 2
    • 2
    • 2
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    AA 179-209, C-Term

    交叉反应

    交叉反应 (详细)

    Calculated cross reactivity: Hu

    产品特性

    CLDN7, CT (CLDN7, CEPTRL2, CPETRL2, Claudin-7) (FITC)

    纯化方法

    Purified by Protein A affinity chromatography.

    免疫原

    CLDN7 antibody is generated from rabbits immunized with a KLH conjugated synthetic peptide between 179-209 amino acids from the C-terminal region of human CLDN7.

    亚型

    IgG
  • 应用备注

    Optimal working conditions should be determined by the investigator.

    限制

    仅限研究用
  • 状态

    Liquid

    缓冲液

    Supplied as a liquid in PBS, pH 7.2.

    储存条件

    -20 °C

    储存方法

    -20°C
  • 抗原

    Claudin 7 (CLDN7)

    别名

    CLDN7

    NCBI登录号

    NP_001171951, NP_001298

    UniProt

    O95471

    途径

    Hepatitis C
You are here: